Homologous News and Research

RSS
Novel mechanism by which “good” bacteria colonize the gut discovered

Novel mechanism by which “good” bacteria colonize the gut discovered

A high-throughput CAMP assay for the evaluation of the vitamin D-dependent antimicrobial response

A high-throughput CAMP assay for the evaluation of the vitamin D-dependent antimicrobial response

TbID-based proteomic profiling in meiotic cells helps identify proximate proteins in A. thaliana

TbID-based proteomic profiling in meiotic cells helps identify proximate proteins in A. thaliana

Study unveils a key factor involved in the DNA damage response and repair

Study unveils a key factor involved in the DNA damage response and repair

Antibody levels from prime COVID-19 mRNA vaccine influences the efficacy of booster doses

Antibody levels from prime COVID-19 mRNA vaccine influences the efficacy of booster doses

Meta-analysis on COVID-19 vaccine effectiveness in association with antibody titers

Meta-analysis on COVID-19 vaccine effectiveness in association with antibody titers

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Genome editing techniques based on bacterial-artificial-chromosome in herpesvirus research

Genome editing techniques based on bacterial-artificial-chromosome in herpesvirus research

Is the advantage conferred by the heterologous regimen conserved after a booster dose of mRNA-based COVID-19 vaccine?

Is the advantage conferred by the heterologous regimen conserved after a booster dose of mRNA-based COVID-19 vaccine?

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

Study suggests SARS-CoV-2 is likely to only infect placental mammals

Study suggests SARS-CoV-2 is likely to only infect placental mammals

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Study characterizes mutations in neuraminidase of human-like H5N1 influenza viruses

Study characterizes mutations in neuraminidase of human-like H5N1 influenza viruses

The effectiveness of intranasal COVID-19 vaccination in healthy adults

The effectiveness of intranasal COVID-19 vaccination in healthy adults

Researchers report a heterologous vaccination strategy against IBV in Chickens

Researchers report a heterologous vaccination strategy against IBV in Chickens

Could novel lineages eventually dominate the viral population?

Could novel lineages eventually dominate the viral population?

Third booster dose of SARS-CoV-2 vaccine associated with 90% reduction in COVID-19 deaths

Third booster dose of SARS-CoV-2 vaccine associated with 90% reduction in COVID-19 deaths

Study evaluates SARS-CoV-2-specific antibody response in human milk

Study evaluates SARS-CoV-2-specific antibody response in human milk

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.